Published in Schweiz Med Wochenschr on January 28, 1980
Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med (1998) 25.41
Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol (2000) 7.94
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. Kidney Int (2000) 3.86
Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. Cancer Res (1999) 3.41
Combined report on regular dialysis and transplantation in Europe. X, 1979. Proc Eur Dial Transplant Assoc (1980) 3.12
Mechanism of glomerulotubular balance. I. Effect of aortic constriction and elevated ureteropelvic pressure on glomerular filtration rate, fractional reabsorption, transit time, and tubular size in the proximal tubule of the rat. J Clin Invest (1966) 2.96
Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res (1999) 2.79
Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med (2000) 2.63
Combined Report on Regular Dialysis and Transplantation in Europe, IX, 1978. Proc Eur Dial Transplant Assoc (1979) 2.27
High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am J Pathol (1999) 2.22
Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol (2001) 2.20
Mechanism of glomerulotubular balance. II. Regulation of proximal tubular reabsorption by tubular volume, as studied by stopped-flow microperfusion. J Clin Invest (1966) 2.19
Quantitative studies of in situ immune complex glomerulonephritis in the rat induced by planted, cationized antigen. J Exp Med (1982) 2.00
Combined report on regular dialysis and transplantation in Europe, XIII, 1982. Proc Eur Dial Transplant Assoc (1983) 1.97
Patterns of metastasis in muscle-invasive bladder cancer (pT2-4): An autopsy study on 367 patients. Urol Int (1999) 1.92
Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases. N Engl J Med (1992) 1.91
Combined report on regular dialysis and transplantation in Europe, VIII, 1977. Proc Eur Dial Transplant Assoc (1978) 1.85
Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol (1999) 1.83
High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol (2000) 1.82
Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst (1999) 1.81
Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res (1997) 1.76
Combined Report on Regular Dialysis and Transplantation of Children in Europe, 1978. Proc Eur Dial Transplant Assoc (1979) 1.73
Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation (1999) 1.71
Mortality and morbidity of reusing dialysers. A report by the registration committee of the European Dialysis and Transplant Association. Br Med J (1978) 1.70
Combined report on regular dialysis and transplantation in Europe, XI, 1980. Proc Eur Dial Transplant Assoc (1981) 1.68
Pathology of resolving polyomavirus-associated nephropathy. Am J Transplant (2013) 1.65
High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res (2001) 1.64
Combined report on regular dialysis and transplantation of children in Europe, 1977. Proc Eur Dial Transplant Assoc (1978) 1.64
Combined report on regular dialysis and transplantation in Europe, VII, 1976. Proc Eur Dial Transplant Assoc (1977) 1.63
The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation--data on four cases and review of the literature. Transplantation (1993) 1.61
Reversible acute renal failure from gross haematuria due to glomerulonephritis: not only in IgA nephropathy and not associated with intratubular obstruction. Nephrol Dial Transplant (1995) 1.57
Combined report on regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant (1991) 1.56
Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria. Lab Invest (1991) 1.55
Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant (1992) 1.53
Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res (1996) 1.52
Cytomegalovirus infection and graft rejection in renal transplantation. Transplantation (2001) 1.50
Factors associated with early remission of type I diabetes in children treated with cyclosporine. N Engl J Med (1988) 1.47
Analysis of glycosaminoglycans in human serum after oral administration of chondroitin sulfate. Rheumatol Int (1992) 1.46
Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. Cancer Res (2000) 1.45
Metastatic primitive neuroectodermal tumor of the kidney in adults. Eur Urol (2001) 1.44
The lady who had a remote history of ovarian malignancy and developed thrombotic microangiopathy. Nephrol Dial Transplant (2000) 1.43
Platelet-activating factor receptor antagonist improves renal function and glomerular lesions in renal ablation. J Lab Clin Med (1994) 1.41
Hypernatraemia and polyuria in a patient with acute myeloid leukaemia and allogeneic bone marrow transplant. Nephrol Dial Transplant (1998) 1.41
Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer (2000) 1.41
Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol (2001) 1.41
Longterm low dose cyclosporine in patients with rheumatoid arthritis: renal function loss without structural nephropathy. J Rheumatol (1996) 1.40
BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant (2000) 1.39
Analgesic nephropathy. Nephrol Dial Transplant (1996) 1.38
Combined report on regular dialysis and transplantation in Europe, II, 1971. Proc Eur Dial Transplant Assoc (1972) 1.36
EGF-r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization. J Pathol (1998) 1.34
Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am J Pathol (1998) 1.34
Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am J Transplant (2010) 1.33
Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice. Am J Pathol (1994) 1.32
Hypokalaemia, metabolic alkalosis, and hypernatraemia due to "massive" sodium penicillin therapy. Br Med J (1968) 1.31
Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol (2002) 1.30
KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer. Oncogene (2006) 1.29
Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy. J Pathol (1996) 1.29
Evaluation of the clonal relationship between primary and metastatic renal cell carcinoma by comparative genomic hybridization. Am J Pathol (1999) 1.25
Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. Am J Pathol (1998) 1.24
Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization. Prostate (2001) 1.23
Variants of citrullinaemia. Arch Dis Child (1973) 1.20
Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma of clinical stage IB detected by comparative genomic hybridization. Cancer Res (1999) 1.20
Malignant diseases in patients treated by dialysis and transplantation in Europe. Transplant Proc (1981) 1.18
Epidermal growth factor receptor expression is associated with rapid tumor cell proliferation in renal cell carcinoma. Hum Pathol (1997) 1.17
Tumour necrosis factor receptor distribution in human lymphoid tissue. Immunology (1991) 1.16
Combined report on regular dialysis and transplantation in Europe, 3, 1972. Proc Eur Dial Transplant Assoc (1973) 1.15
Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res (1999) 1.15
Collagen type III glomerulopathy: a new idiopathic glomerular disease. Am J Nephrol (1991) 1.14
Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res (1993) 1.14
Successful pregnancies in women on renal replacement therapy: report from the EDTA Registry. Nephrol Dial Transplant (1992) 1.14
Prognostic significance of Bcl-2 in clinically localized prostate cancer. Am J Pathol (1996) 1.13
[Autopsy and modern medicine]. Praxis (Bern 1994) (1999) 1.13
Distribution of the cyclosporine binding protein cyclophilin in human tissues. Immunology (1991) 1.13
CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A. Am J Pathol (2001) 1.12
Systemic karyomegaly associated with chronic interstitial nephritis. A new disease entity? Clin Nephrol (1979) 1.11
Calretinin as a marker for cardiac myxoma. Diagnostic and histogenetic considerations. Am J Clin Pathol (2000) 1.10
Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization. Cancer Res (1998) 1.09
Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer. BJU Int (2000) 1.09
Case-control study to determine the cause of sclerosing peritoneal disease. Nephrol Dial Transplant (1988) 1.08
Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer (1994) 1.08
Long-term outcome of Schönlein-Henoch nephritis in the adult. Clin Nephrol (1989) 1.07
[Web-based learning tools in pathology]. Pathologe (2003) 1.07
Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer. Cancer Res (1999) 1.06
Chronic interstitial nephritis in Whipple's disease. Klin Wochenschr (1983) 1.05
Pretransplant risk assessment in renal allograft recipients using virtual crossmatching. Am J Transplant (2007) 1.05
[Adaptive intimal fibrosis of arteries]. Virchows Arch Pathol Anat Physiol Klin Med (1967) 1.05
Nephronophthisis (medullary cystic disease of the kidney). A study using electron microscopy, immunofluorescence, and a review of the morphological findings. Helv Paediatr Acta (1980) 1.03
No complement receptor 1 stumps on podocytes in human glomerulopathies. Kidney Int (2001) 1.02
Chromosomal imbalances in small cell carcinomas of the urinary bladder. J Pathol (1999) 1.02
Renal disease in essential mixed cryoglobulinaemia. Long-term follow-up of 44 patients. Q J Med (1981) 1.02
Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer. Am J Pathol (1997) 1.01
Ocular pathology in light chain deposition disease. Eur J Ophthalmol (1995) 1.01
Cyclosporine--relationship of side effects to mode of action. Transplantation (1988) 1.00
Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization. Am J Pathol (1994) 1.00
Renal lesions in familial lecithin-cholesterol acyltransferase deficiency. Ultrastructural heterogeneity of glomerular changes. Am J Nephrol (1986) 0.99